Clinical trials

  • MK-1084 for Colorectal cancer (KRAS G12C-mutant) | Locally advanced unresectable colorectal cancer | Metastatic colorectal cancer
  • Pneumococcal polysaccharide serotypes conjugated to CRM197 (20-valent pneumococcal conjugate vaccine) for Acute febrile illness | Increased risk for invasive pneumococcal disease
  • anti-CD19 CAR-T cells for Non-Hodgkin lymphoma|Diffuse large B-cell lymphoma (DLBCL)|High-grade B-cell lymphoma (HGBL)
  • ANAKINRA for Intracerebral haemorrhage
  • EPLERENONE for End-stage renal disease|Renal transplantation
  • FONDAPARINUX SODIUM for Non-ST-elevation myocardial infarction (NSTEMI)
  • BLEOMYCIN for Rectal cancer | Colorectal cancer
  • Selumetinib for Neurofibromatosis type 1 (NF1) | Plexiform neurofibroma
  • Carboplatin for Head and neck squamous cell carcinoma
  • ISATUXIMAB for Multiple myeloma|Newly diagnosed multiple myeloma
  • 2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE for Concussion | Intracerebral hemorrhage | Traumatic brain injury | Subarachnoid haemorrhage
  • ATEZOLIZUMAB for Microsatellite-stable (MSS/pMMR) colorectal cancer with liver-dominant metastasis